发明名称 |
Use of LCK inhibitors for treatment of immunologic diseases |
摘要 |
<p>The invention relates to a method of treating immunologic diseases or pathological conditions involving an immunologic component using certain Lck inhibitors already known as kinase inhibitors for therapy in oncology, optionally in combination with one or more other drugs selected from NSAIDs, steroids, DMARDs, immunsuppressives, biologic response modifiers and antinfectives, pharmaceutical compositions comprising said Lck inhibitors together with said other drugs, and the use of the Lck inhibitors for the manufacture of a pharmaceutical composition for the treatment of immunologic diseases or pathological conditions involving an immunologic component.</p> |
申请公布号 |
EP2281561(A2) |
申请公布日期 |
2011.02.09 |
申请号 |
EP20100184940 |
申请日期 |
2003.08.11 |
申请人 |
BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG |
发明人 |
ROTH, GERALD JUERGEN;HAUPTMANN, RUDOLF;HILBERG, FRANK;COLBATZKY, FLORIAN;ERNST, STEFFEN;HECKEL, ARMIN;STEFANIC, MARTIN, FRIEDRICH;WALTER, RAINER |
分类号 |
A61K31/404;A61K31/454;A61K31/517;A61K45/06;A61P1/00;A61P3/10;A61P5/48;A61P11/06;A61P17/06;A61P19/02;A61P25/00;A61P29/00;A61P37/00;A61P37/06;A61P41/00 |
主分类号 |
A61K31/404 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|